Oncology News

Tawam Hospital, in affiliation with Johns Hopkins Medicine and part of the SEHA healthcare system, is hosting the third edition of the Emirates Oncology Conference and 14th Pan-Arab Cancer Congress from November 13 to 15, 2014 at the Emirates Palace hotel in Abu Dhabi.

The Molecular Oncology Diagnostics Laboratory will focus on breast, lung, melanoma and colorectal cancer patient samples when it first opens.

On friday afternoon mom was given some terrible news from her daughter. Her lab work came back abnormal & she told her oncologist that her back was hurting really bad.

The Nuffield Health Brighton Hospital was given a Macmillan Quality Environment Mark for offering high standards of care for people affected by cancer.

Local medical institutions work for your health Here is a list of the major medical institutions in the area.

But the brave Burdekin teen has refused to let her battle against an undiagnosed brain tumour hold her back from fighting for the lives of children with cancer.

Oliver Fetzer says that he may not have opted to bring his company, Cerulean Pharma, public in April had it not been for a discovery a few months earlier that showed his main cancer drug had one advantage he hadn't previously known anything about.

Pending data by year-end, we expect GILD to pay above fair value >100% upside for MGNX, reflecting its scarcity value delivering both immuno-oncology exposure and high-throughput drug development.

ROS1 fusion genes were successfully detected independent of gender or smoking history in young East Asian patients with lung adenocarcinoma , a histological subgroup in non-small cell lung cancer , using multiplex reverse transcriptase-polymerase chain reaction and immunohistochemistry diagnostic tests.

Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you.

While she always wanted to be a doctor, she first provided care as a nurse, and some of her early experiences helping cancer patients encouraged her to specialize in radiation oncology as a physician.

The provincial budget is a factor when it comes to delays in approving new cancer drugs, say P.E.I. health officials.

At the same time, mortality due to cancer cases is estimated to be at 0.8 million, Health Minister Harsh Vardhan told the Rajya Sabha in a written reply.

Advaxis, Inc. , a clinical-stage biotechnology company developing cancer immunotherapies, has entered into a clinical trial collaboration with MedImmune, the global biologics research and development arm of AstraZeneca.

The University of Texas MD Anderson Cancer Center is pleased to announce that one of the world's preeminent experts in breast cancer research and treatment, V. Craig Jordan, Ph.D., will join the institution's efforts to end cancer.

Jordan Foster is only five years old, but her father told WAVY.com she saw ads about hosting lemonade stands for Anthem's LemonAid for Children's Miracle Network Hospitals and decided to participate.

Twenty years ago, Pam Roberts was diagnosed with breast cancer. Every week through treatment and rehabilitation, Roberts attended a writing workshop, where she found that no matter what prompt was given, she'd write about her experience with cancer.

Champions Oncology , a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced it will report its financial and operational results for the fourth quarter and fiscal year ended April 30, 2014, on Thursday, July 24, 2014, after market close.

This clinical trial is called STARTRK-1, which stands for A/B/C, and is a Phase I/IIa, multicenter, single-arm, open-label clinical trial of continuous daily dosing of oral RXDX-101 in adult patients with locally advanced or metastatic cancer confirmed to be positive for relevant molecular alterations.

In what's being described as a significant show of support for immunotherapy research in the treatment of cancer, the National Institutes of Health has awarded a $1.6 million, five-year grant to a Providence Cancer Center researcher.